GOSSAMER BIO, INC. (GOSS) Return on equity 2022–2024
GOSSAMER BIO, INC. (GOSS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-191.7%FY2024 · since FY2022: -1899.3% → -191.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -191.7% | +94.8 pp |
| FY2023 | -286.5% | +1612.8 pp |
| FY2022 | -1899.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More GOSS financial trends
GOSS RevenueGOSS Net incomeGOSS Net marginGOSS Gross profitGOSS Gross marginGOSS Operating incomeGOSS Operating marginGOSS Operating cash flowGOSS Free cash flowGOSS Capital expendituresGOSS Stock buybacksGOSS Dividends paidGOSS Total assetsGOSS Total liabilitiesGOSS Shareholders’ equityGOSS overview →